BD (NYSE:BDX) announced today that it increased its manufacturing capacity and domestic supply for syringes and needles.
Franklin Lakes, N.J.-based BD’s new syringe and needle manufacturing lines, which were completed on an accelerated timeline, represent BD’s partnership with Department of Health and Human Services’ (HHS) Assistant Secretary for Preparedness and Response (ASPR).
Get the full story at our sister site, Drug Delivery Business News.